The global market for Renal Anemia Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Renal Anemia Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renal Anemia Therapeutics.

The Renal Anemia Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Renal Anemia Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Renal Anemia Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Renal Anemia Therapeutics Market Report

Report Metric	Details
Report Name	Renal Anemia Therapeutics Market
CAGR	5%
Segment by Type	DS-1093 EPO-018B FG-2216 JTZ-951 MDGN-201 MMP-0101 Others
Segment by Application	Hospital Research Center Clinic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer AG, BIOCAD, CCM Duopharma Biotech Bhd., Chong Kun Dang Pharmaceutical Corp., Daiichi Sankyo Company, Limited, Dong-A Socio Group, Dr. Reddy's Laboratories Limited, Eli Lilly and Company, FibroGen, Inc., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Japan Tobacco Inc., JCR Pharmaceuticals Co., Ltd., Jiangsu Hansoh Pharmaceutical Co., Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Renal Anemia Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Renal Anemia Therapeutics Market report?

Ans: The main players in the Renal Anemia Therapeutics Market are Bayer AG, BIOCAD, CCM Duopharma Biotech Bhd., Chong Kun Dang Pharmaceutical Corp., Daiichi Sankyo Company, Limited, Dong-A Socio Group, Dr. Reddy's Laboratories Limited, Eli Lilly and Company, FibroGen, Inc., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Japan Tobacco Inc., JCR Pharmaceuticals Co., Ltd., Jiangsu Hansoh Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Renal Anemia Therapeutics Market report?

Ans: The Applications covered in the Renal Anemia Therapeutics Market report are Hospital, Research Center, Clinic

What are the Type segmentation covered in the Renal Anemia Therapeutics Market report?

Ans: The Types covered in the Renal Anemia Therapeutics Market report are DS-1093, EPO-018B, FG-2216, JTZ-951, MDGN-201, MMP-0101, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Renal Anemia Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 DS-1093

1.2.3 EPO-018B

1.2.4 FG-2216

1.2.5 JTZ-951

1.2.6 MDGN-201

1.2.7 MMP-0101

1.2.8 Others

1.3 Market by Application

1.3.1 Global Renal Anemia Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Research Center

1.3.4 Clinic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Renal Anemia Therapeutics Market Perspective (2020-2031)

2.2 Global Renal Anemia Therapeutics Growth Trends by Region

2.2.1 Global Renal Anemia Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Renal Anemia Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Renal Anemia Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Renal Anemia Therapeutics Market Dynamics

2.3.1 Renal Anemia Therapeutics Industry Trends

2.3.2 Renal Anemia Therapeutics Market Drivers

2.3.3 Renal Anemia Therapeutics Market Challenges

2.3.4 Renal Anemia Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Renal Anemia Therapeutics Players by Revenue

3.1.1 Global Top Renal Anemia Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Renal Anemia Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Renal Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Renal Anemia Therapeutics Revenue

3.4 Global Renal Anemia Therapeutics Market Concentration Ratio

3.4.1 Global Renal Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Renal Anemia Therapeutics Revenue in 2024

3.5 Global Key Players of Renal Anemia Therapeutics Head office and Area Served

3.6 Global Key Players of Renal Anemia Therapeutics, Product and Application

3.7 Global Key Players of Renal Anemia Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Renal Anemia Therapeutics Breakdown Data by Type

4.1 Global Renal Anemia Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Renal Anemia Therapeutics Forecasted Market Size by Type (2026-2031)

5 Renal Anemia Therapeutics Breakdown Data by Application

5.1 Global Renal Anemia Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Renal Anemia Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Renal Anemia Therapeutics Market Size (2020-2031)

6.2 North America Renal Anemia Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Renal Anemia Therapeutics Market Size by Country (2020-2025)

6.4 North America Renal Anemia Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Renal Anemia Therapeutics Market Size (2020-2031)

7.2 Europe Renal Anemia Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Renal Anemia Therapeutics Market Size by Country (2020-2025)

7.4 Europe Renal Anemia Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Renal Anemia Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Renal Anemia Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Renal Anemia Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Renal Anemia Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Renal Anemia Therapeutics Market Size (2020-2031)

9.2 Latin America Renal Anemia Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Renal Anemia Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Renal Anemia Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Renal Anemia Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Renal Anemia Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Renal Anemia Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Renal Anemia Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer AG

11.1.1 Bayer AG Company Details

11.1.2 Bayer AG Business Overview

11.1.3 Bayer AG Renal Anemia Therapeutics Introduction

11.1.4 Bayer AG Revenue in Renal Anemia Therapeutics Business (2020-2025)

11.1.5 Bayer AG Recent Development

11.2 BIOCAD

11.2.1 BIOCAD Company Details

11.2.2 BIOCAD Business Overview

11.2.3 BIOCAD Renal Anemia Therapeutics Introduction

11.2.4 BIOCAD Revenue in Renal Anemia Therapeutics Business (2020-2025)

11.2.5 BIOCAD Recent Development

11.3 CCM Duopharma Biotech Bhd.

11.3.1 CCM Duopharma Biotech Bhd. Company Details

11.3.2 CCM Duopharma Biotech Bhd. Business Overview

11.3.3 CCM Duopharma Biotech Bhd. Renal Anemia Therapeutics Introduction

11.3.4 CCM Duopharma Biotech Bhd. Revenue in Renal Anemia Therapeutics Business (2020-2025)

11.3.5 CCM Duopharma Biotech Bhd. Recent Development

11.4 Chong Kun Dang Pharmaceutical Corp.

11.4.1 Chong Kun Dang Pharmaceutical Corp. Company Details

11.4.2 Chong Kun Dang Pharmaceutical Corp. Business Overview

11.4.3 Chong Kun Dang Pharmaceutical Corp. Renal Anemia Therapeutics Introduction

11.4.4 Chong Kun Dang Pharmaceutical Corp. Revenue in Renal Anemia Therapeutics Business (2020-2025)

11.4.5 Chong Kun Dang Pharmaceutical Corp. Recent Development

11.5 Daiichi Sankyo Company, Limited

11.5.1 Daiichi Sankyo Company, Limited Company Details

11.5.2 Daiichi Sankyo Company, Limited Business Overview

11.5.3 Daiichi Sankyo Company, Limited Renal Anemia Therapeutics Introduction

11.5.4 Daiichi Sankyo Company, Limited Revenue in Renal Anemia Therapeutics Business (2020-2025)

11.5.5 Daiichi Sankyo Company, Limited Recent Development

11.6 Dong-A Socio Group

11.6.1 Dong-A Socio Group Company Details

11.6.2 Dong-A Socio Group Business Overview

11.6.3 Dong-A Socio Group Renal Anemia Therapeutics Introduction

11.6.4 Dong-A Socio Group Revenue in Renal Anemia Therapeutics Business (2020-2025)

11.6.5 Dong-A Socio Group Recent Development

11.7 Dr. Reddy's Laboratories Limited

11.7.1 Dr. Reddy's Laboratories Limited Company Details

11.7.2 Dr. Reddy's Laboratories Limited Business Overview

11.7.3 Dr. Reddy's Laboratories Limited Renal Anemia Therapeutics Introduction

11.7.4 Dr. Reddy's Laboratories Limited Revenue in Renal Anemia Therapeutics Business (2020-2025)

11.7.5 Dr. Reddy's Laboratories Limited Recent Development

11.8 Eli Lilly and Company

11.8.1 Eli Lilly and Company Company Details

11.8.2 Eli Lilly and Company Business Overview

11.8.3 Eli Lilly and Company Renal Anemia Therapeutics Introduction

11.8.4 Eli Lilly and Company Revenue in Renal Anemia Therapeutics Business (2020-2025)

11.8.5 Eli Lilly and Company Recent Development

11.9 FibroGen, Inc.

11.9.1 FibroGen, Inc. Company Details

11.9.2 FibroGen, Inc. Business Overview

11.9.3 FibroGen, Inc. Renal Anemia Therapeutics Introduction

11.9.4 FibroGen, Inc. Revenue in Renal Anemia Therapeutics Business (2020-2025)

11.9.5 FibroGen, Inc. Recent Development

11.10 GlaxoSmithKline Plc

11.10.1 GlaxoSmithKline Plc Company Details

11.10.2 GlaxoSmithKline Plc Business Overview

11.10.3 GlaxoSmithKline Plc Renal Anemia Therapeutics Introduction

11.10.4 GlaxoSmithKline Plc Revenue in Renal Anemia Therapeutics Business (2020-2025)

11.10.5 GlaxoSmithKline Plc Recent Development

11.11 Intas Pharmaceuticals Ltd.

11.11.1 Intas Pharmaceuticals Ltd. Company Details

11.11.2 Intas Pharmaceuticals Ltd. Business Overview

11.11.3 Intas Pharmaceuticals Ltd. Renal Anemia Therapeutics Introduction

11.11.4 Intas Pharmaceuticals Ltd. Revenue in Renal Anemia Therapeutics Business (2020-2025)

11.11.5 Intas Pharmaceuticals Ltd. Recent Development

11.12 Japan Tobacco Inc.

11.12.1 Japan Tobacco Inc. Company Details

11.12.2 Japan Tobacco Inc. Business Overview

11.12.3 Japan Tobacco Inc. Renal Anemia Therapeutics Introduction

11.12.4 Japan Tobacco Inc. Revenue in Renal Anemia Therapeutics Business (2020-2025)

11.12.5 Japan Tobacco Inc. Recent Development

11.13 JCR Pharmaceuticals Co., Ltd.

11.13.1 JCR Pharmaceuticals Co., Ltd. Company Details

11.13.2 JCR Pharmaceuticals Co., Ltd. Business Overview

11.13.3 JCR Pharmaceuticals Co., Ltd. Renal Anemia Therapeutics Introduction

11.13.4 JCR Pharmaceuticals Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2020-2025)

11.13.5 JCR Pharmaceuticals Co., Ltd. Recent Development

11.14 Jiangsu Hansoh Pharmaceutical Co., Ltd.

11.14.1 Jiangsu Hansoh Pharmaceutical Co., Ltd. Company Details

11.14.2 Jiangsu Hansoh Pharmaceutical Co., Ltd. Business Overview

11.14.3 Jiangsu Hansoh Pharmaceutical Co., Ltd. Renal Anemia Therapeutics Introduction

11.14.4 Jiangsu Hansoh Pharmaceutical Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2020-2025)

11.14.5 Jiangsu Hansoh Pharmaceutical Co., Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bayer

BIOCAD

CCM Duopharma Biotech Bhd.

Chong Kun Dang Pharmaceutical Corp

Daiichi Sankyo Company Limited

Dong-A Socio Group

Dr. Reddy's Laboratories Limited

Eli Lilly and Company

FibroGen Inc

GlaxoSmithKline PLC

Intas Pharmaceuticals Ltd

Japan Tobacco Inc

JCR Pharmaceuticals Co Ltd

Jiangsu Hansoh Pharmaceutical Co., Ltd.

List of Tables

Table 1. Global Renal Anemia Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of DS-1093

Table 3. Key Players of EPO-018B

Table 4. Key Players of FG-2216

Table 5. Key Players of JTZ-951

Table 6. Key Players of MDGN-201

Table 7. Key Players of MMP-0101

Table 8. Key Players of Others

Table 9. Global Renal Anemia Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Renal Anemia Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Renal Anemia Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Renal Anemia Therapeutics Market Share by Region (2020-2025)

Table 13. Global Renal Anemia Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Renal Anemia Therapeutics Market Share by Region (2026-2031)

Table 15. Renal Anemia Therapeutics Market Trends

Table 16. Renal Anemia Therapeutics Market Drivers

Table 17. Renal Anemia Therapeutics Market Challenges

Table 18. Renal Anemia Therapeutics Market Restraints

Table 19. Global Renal Anemia Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Renal Anemia Therapeutics Market Share by Players (2020-2025)

Table 21. Global Top Renal Anemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Anemia Therapeutics as of 2024)

Table 22. Ranking of Global Top Renal Anemia Therapeutics Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Renal Anemia Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Renal Anemia Therapeutics, Headquarters and Area Served

Table 25. Global Key Players of Renal Anemia Therapeutics, Product and Application

Table 26. Global Key Players of Renal Anemia Therapeutics, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Renal Anemia Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Renal Anemia Therapeutics Revenue Market Share by Type (2020-2025)

Table 30. Global Renal Anemia Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Renal Anemia Therapeutics Revenue Market Share by Type (2026-2031)

Table 32. Global Renal Anemia Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Renal Anemia Therapeutics Revenue Market Share by Application (2020-2025)

Table 34. Global Renal Anemia Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Renal Anemia Therapeutics Revenue Market Share by Application (2026-2031)

Table 36. North America Renal Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Renal Anemia Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Renal Anemia Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Renal Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Renal Anemia Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Renal Anemia Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Renal Anemia Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Renal Anemia Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Renal Anemia Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Renal Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Renal Anemia Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Renal Anemia Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Renal Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Renal Anemia Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Renal Anemia Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 51. Bayer AG Company Details

Table 52. Bayer AG Business Overview

Table 53. Bayer AG Renal Anemia Therapeutics Product

Table 54. Bayer AG Revenue in Renal Anemia Therapeutics Business (2020-2025) & (US$ Million)

Table 55. Bayer AG Recent Development

Table 56. BIOCAD Company Details

Table 57. BIOCAD Business Overview

Table 58. BIOCAD Renal Anemia Therapeutics Product

Table 59. BIOCAD Revenue in Renal Anemia Therapeutics Business (2020-2025) & (US$ Million)

Table 60. BIOCAD Recent Development

Table 61. CCM Duopharma Biotech Bhd. Company Details

Table 62. CCM Duopharma Biotech Bhd. Business Overview

Table 63. CCM Duopharma Biotech Bhd. Renal Anemia Therapeutics Product

Table 64. CCM Duopharma Biotech Bhd. Revenue in Renal Anemia Therapeutics Business (2020-2025) & (US$ Million)

Table 65. CCM Duopharma Biotech Bhd. Recent Development

Table 66. Chong Kun Dang Pharmaceutical Corp. Company Details

Table 67. Chong Kun Dang Pharmaceutical Corp. Business Overview

Table 68. Chong Kun Dang Pharmaceutical Corp. Renal Anemia Therapeutics Product

Table 69. Chong Kun Dang Pharmaceutical Corp. Revenue in Renal Anemia Therapeutics Business (2020-2025) & (US$ Million)

Table 70. Chong Kun Dang Pharmaceutical Corp. Recent Development

Table 71. Daiichi Sankyo Company, Limited Company Details

Table 72. Daiichi Sankyo Company, Limited Business Overview

Table 73. Daiichi Sankyo Company, Limited Renal Anemia Therapeutics Product

Table 74. Daiichi Sankyo Company, Limited Revenue in Renal Anemia Therapeutics Business (2020-2025) & (US$ Million)

Table 75. Daiichi Sankyo Company, Limited Recent Development

Table 76. Dong-A Socio Group Company Details

Table 77. Dong-A Socio Group Business Overview

Table 78. Dong-A Socio Group Renal Anemia Therapeutics Product

Table 79. Dong-A Socio Group Revenue in Renal Anemia Therapeutics Business (2020-2025) & (US$ Million)

Table 80. Dong-A Socio Group Recent Development

Table 81. Dr. Reddy's Laboratories Limited Company Details

Table 82. Dr. Reddy's Laboratories Limited Business Overview

Table 83. Dr. Reddy's Laboratories Limited Renal Anemia Therapeutics Product

Table 84. Dr. Reddy's Laboratories Limited Revenue in Renal Anemia Therapeutics Business (2020-2025) & (US$ Million)

Table 85. Dr. Reddy's Laboratories Limited Recent Development

Table 86. Eli Lilly and Company Company Details

Table 87. Eli Lilly and Company Business Overview

Table 88. Eli Lilly and Company Renal Anemia Therapeutics Product

Table 89. Eli Lilly and Company Revenue in Renal Anemia Therapeutics Business (2020-2025) & (US$ Million)

Table 90. Eli Lilly and Company Recent Development

Table 91. FibroGen, Inc. Company Details

Table 92. FibroGen, Inc. Business Overview

Table 93. FibroGen, Inc. Renal Anemia Therapeutics Product

Table 94. FibroGen, Inc. Revenue in Renal Anemia Therapeutics Business (2020-2025) & (US$ Million)

Table 95. FibroGen, Inc. Recent Development

Table 96. GlaxoSmithKline Plc Company Details

Table 97. GlaxoSmithKline Plc Business Overview

Table 98. GlaxoSmithKline Plc Renal Anemia Therapeutics Product

Table 99. GlaxoSmithKline Plc Revenue in Renal Anemia Therapeutics Business (2020-2025) & (US$ Million)

Table 100. GlaxoSmithKline Plc Recent Development

Table 101. Intas Pharmaceuticals Ltd. Company Details

Table 102. Intas Pharmaceuticals Ltd. Business Overview

Table 103. Intas Pharmaceuticals Ltd. Renal Anemia Therapeutics Product

Table 104. Intas Pharmaceuticals Ltd. Revenue in Renal Anemia Therapeutics Business (2020-2025) & (US$ Million)

Table 105. Intas Pharmaceuticals Ltd. Recent Development

Table 106. Japan Tobacco Inc. Company Details

Table 107. Japan Tobacco Inc. Business Overview

Table 108. Japan Tobacco Inc. Renal Anemia Therapeutics Product

Table 109. Japan Tobacco Inc. Revenue in Renal Anemia Therapeutics Business (2020-2025) & (US$ Million)

Table 110. Japan Tobacco Inc. Recent Development

Table 111. JCR Pharmaceuticals Co., Ltd. Company Details

Table 112. JCR Pharmaceuticals Co., Ltd. Business Overview

Table 113. JCR Pharmaceuticals Co., Ltd. Renal Anemia Therapeutics Product

Table 114. JCR Pharmaceuticals Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2020-2025) & (US$ Million)

Table 115. JCR Pharmaceuticals Co., Ltd. Recent Development

Table 116. Jiangsu Hansoh Pharmaceutical Co., Ltd. Company Details

Table 117. Jiangsu Hansoh Pharmaceutical Co., Ltd. Business Overview

Table 118. Jiangsu Hansoh Pharmaceutical Co., Ltd. Renal Anemia Therapeutics Product

Table 119. Jiangsu Hansoh Pharmaceutical Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2020-2025) & (US$ Million)

Table 120. Jiangsu Hansoh Pharmaceutical Co., Ltd. Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Renal Anemia Therapeutics Picture

Figure 2. Global Renal Anemia Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Renal Anemia Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. DS-1093 Features

Figure 5. EPO-018B Features

Figure 6. FG-2216 Features

Figure 7. JTZ-951 Features

Figure 8. MDGN-201 Features

Figure 9. MMP-0101 Features

Figure 10. Others Features

Figure 11. Global Renal Anemia Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global Renal Anemia Therapeutics Market Share by Application: 2024 VS 2031

Figure 13. Hospital Case Studies

Figure 14. Research Center Case Studies

Figure 15. Clinic Case Studies

Figure 16. Renal Anemia Therapeutics Report Years Considered

Figure 17. Global Renal Anemia Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Renal Anemia Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Renal Anemia Therapeutics Market Share by Region: 2024 VS 2031

Figure 20. Global Renal Anemia Therapeutics Market Share by Players in 2024

Figure 21. Global Top Renal Anemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Anemia Therapeutics as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Renal Anemia Therapeutics Revenue in 2024

Figure 23. North America Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Renal Anemia Therapeutics Market Share by Country (2020-2031)

Figure 25. United States Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Renal Anemia Therapeutics Market Share by Country (2020-2031)

Figure 29. Germany Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Renal Anemia Therapeutics Market Share by Region (2020-2031)

Figure 37. China Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Renal Anemia Therapeutics Market Share by Country (2020-2031)

Figure 45. Mexico Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Renal Anemia Therapeutics Market Share by Country (2020-2031)

Figure 49. Turkey Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Renal Anemia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Bayer AG Revenue Growth Rate in Renal Anemia Therapeutics Business (2020-2025)

Figure 53. BIOCAD Revenue Growth Rate in Renal Anemia Therapeutics Business (2020-2025)

Figure 54. CCM Duopharma Biotech Bhd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2020-2025)

Figure 55. Chong Kun Dang Pharmaceutical Corp. Revenue Growth Rate in Renal Anemia Therapeutics Business (2020-2025)

Figure 56. Daiichi Sankyo Company, Limited Revenue Growth Rate in Renal Anemia Therapeutics Business (2020-2025)

Figure 57. Dong-A Socio Group Revenue Growth Rate in Renal Anemia Therapeutics Business (2020-2025)

Figure 58. Dr. Reddy's Laboratories Limited Revenue Growth Rate in Renal Anemia Therapeutics Business (2020-2025)

Figure 59. Eli Lilly and Company Revenue Growth Rate in Renal Anemia Therapeutics Business (2020-2025)

Figure 60. FibroGen, Inc. Revenue Growth Rate in Renal Anemia Therapeutics Business (2020-2025)

Figure 61. GlaxoSmithKline Plc Revenue Growth Rate in Renal Anemia Therapeutics Business (2020-2025)

Figure 62. Intas Pharmaceuticals Ltd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2020-2025)

Figure 63. Japan Tobacco Inc. Revenue Growth Rate in Renal Anemia Therapeutics Business (2020-2025)

Figure 64. JCR Pharmaceuticals Co., Ltd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2020-2025)

Figure 65. Jiangsu Hansoh Pharmaceutical Co., Ltd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2020-2025)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Renal Disease Treatment Market Research Report 2024

Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Kidney Disease Drugs Market Research Report 2025

Global Kidney Cancer Targeted Therapy Market Research Report 2025

Kidney Fibrosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Kidney Cancer Diagnosis Market Research Report 2025

Rare Kidney Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Complement Drug for Kidney Disease Market Research Report 2024

Global Chemotherapy Induced Anemia Drug Market Research Report 2024

Acute Kidney Injury Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anemia in Pregnancy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Continuous Renal Replacement Therapy Market Research Report 2024

Global Polycystic Kidney Disease Treatment Market Research Report 2025

Global Drug induced Nephrotoxicity Treatment Market Research Report 2025

Drug Induced Immune Hemolytic Anemia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Atypical Hemolytic Uremic Syndrome Drug Market Research Report 2024

Advanced Renal Cell Carcinoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Research Report 2025

Global Renal Cell Cacinoma Drugs Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions